Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.49 |
| ▸ | FAAH | O00519 | 6/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 3/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | POLA1 | P09884 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL116063 | 0.98 | HSP90AA1 (0.48) | HSP90AA1DNM1FAAHHRH3ALDH1A1 | |
| SCHEMBL28487707 | 0.91 | HRH3 (0.62) | FAAHHRH3MEN1KMT2APOLB | |
| SCHEMBL428924 | 0.87 | HRH3 (0.58) | HRH3ALDH1A1MEN1KMT2ATRPV1 | |
| Bromide SCHEMBL8773079 | 0.83 | HRH3 (0.57) | FAAHHRH3MEN1KMT2APOLB | |
| Hydrochloric Acid SCHEMBL10397331 | 0.79 | DNM1 (0.51) | HSP90AA1DNM1FAAHHRH3ALDH1A1 | |
| SCHEMBL29053617 | 0.76 | HSP90AA1 (0.55) | HSP90AA1FAAHHRH3ALDH1A1MEN1 | |
| SCHEMBL496957 | 0.76 | HSP90AA1 (0.55) | HSP90AA1FAAHHRH3ALDH1A1MEN1 | |
| SCHEMBL5592299 | 0.76 | ALDH1A1 (0.66) | HSP90AA1FAAHHRH3ALDH1A1MEN1 | |
| SCHEMBL115462 | 0.75 | FAAH (0.53) | HSP90AA1DNM1FAAHHRH3ALDH1A1 | |
| SCHEMBL23378025 | 0.75 | HSP90AA1 (0.59) | HSP90AA1FAAHHRH3ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116891421-A | Eutectic mixture containing salicylic acid | 株式会社LG生活健康 | 2023-10-17 | — | — | CN | disclosed |
| WO-2019109243-A1 | Cosmetic composition for permanently changing the shape of keratinous fibers | HENKEL AG & CO.KGAA (DE) | 2019-06-13 | — | — | WO | disclosed |
| EP-2393469-B1 | Process of treating hair | RHODIA OPERATIONS (FR) | 2016-10-12 | — | — | EP | disclosed |
| US-20120021025-A1 | AQUEOUS COMPOSITION SUITABLE AS SHAMPOO | RHODIA OPERATIONS (FR) | 2012-01-26 | — | — | US | disclosed |
| EP-2337544-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | Living Proof, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| WO-2010089228-A9 | AQUEOUS COMPOSITION SUITABLE AS SHAMPOO | RHODIA OPERATIONS (FR) | 2011-04-21 | — | — | WO | disclosed |
| WO-2010089228-A1 | AQUEOUS COMPOSITION SUITABLE AS SHAMPOO | RHODIA OPERATIONS (FR) | 2010-08-12 | — | — | WO | disclosed |
| EP-2216010-A1 | Aqueous composition suitable as shampoo | Rhodia Opérations (FR) | 2010-08-11 | — | — | EP | disclosed |
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | CIBA CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
| EP-2120846-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| US-6958148-B1 | Linkage of agents to body tissue using microparticles and transglutaminase | PERICOR SCIENCE, INC. (US) | 2005-10-25 | — | — | US | disclosed |
| US-6919076-B1 | Conjugates of agents and transglutaminase substrate linking molecules | PERICOR SCIENCE, INC. (US) | 2005-07-19 | — | — | US | disclosed |
| US-20040170587-A1 | Method of compatibilizing cationic materials with anionic polymers | LUBRIZOL ADVANCED MATERIALS, INC. | 2004-09-02 | — | — | US | disclosed |
| US-20040052748-A1 | Compositions of anionic polymeric rheology modifiers and cationic materials | LUBRIZOL ADVANCED MATERIALS, INC. | 2004-03-18 | — | — | US | disclosed |
| EP-1303260-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | Pericor Science, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| EP-1203141-A1 | LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1202706-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | MAOA, MAOB, ACMSD | HSP90AA1 1225/4885DNM1 2231/4885FAAH 243/4885 |
| US-20040170587-A1 | Method of compatibilizing cationic materials with anionic polymers | PARN, PARG, PICALM | HSP90AA1 2865/4885DNM1 1070/4885FAAH 4478/4885 |
| US-20040052748-A1 | Compositions of anionic polymeric rheology modifiers and cationic materials | PBRM1, PARG, PARN | HSP90AA1 4282/4885DNM1 1791/4885FAAH 4299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.